High-Dose Chemotherapy for Children with Extragonadal Germ-Cell Tumours
Author Information
Author(s): De Giorgi U, Rosti G, Slavin S, Yaniv I, Harousseau J L, Ladenstein R, Demirer T, Dini G
Primary Institution: Istituto Oncologico Romagnolo-Department of Oncology/Haematology, Santa Maria delle Croci Hospital, Ravenna, Italy
Hypothesis
Can salvage high-dose chemotherapy improve outcomes for children with extragonadal germ-cell tumours?
Conclusion
High-dose chemotherapy can induce long-term remissions in children with extragonadal germ-cell tumours.
Supporting Evidence
- 70% of patients achieved complete remission after treatment.
- 43% of patients are continuously disease-free after a median follow-up of 66 months.
- High-dose chemotherapy was well tolerated with no toxic deaths.
Takeaway
Doctors gave strong medicine to kids with a type of cancer that starts outside the usual places, and many of them got better.
Methodology
The study reviewed data from the European Group for Blood and Marrow Transplantation on 23 children treated with salvage high-dose chemotherapy.
Limitations
The study is based on registry data, which may have incomplete information.
Participant Demographics
Median age was 12 years, with a range from 1 to 20 years; 14 males and 9 females.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website